An Enhanced Patient Journey

Improved Access & Outcomes

An Integrated IOI & MID Program through OnePulse Connect

OnePulse Connect — Patient Journey

From eRx to Outcomes Tracking

1
Rx
Received
2
Benefits
Investigation
3
Prior
Authorization
4
Financial
Assistance
5
Care Path
Selection
6
Patient
SMS
7
Outcomes
Tracking
8
Dashboard

Prescription Received

eRx auto-captured via EHR — patient matched, clinical team notified instantly.

Patient
Maria G.DOB 04/12/1968
Match confirmed
Drug
Ocrevus300 mg / 10 mL
NDC resolved · J0202 mapped
Service model
IOI + MID eligibleICD-10 G35 — MS
Mapped
eRx · EHR
OnePulse Connect
Clinical team notified
Patient SMS queued

Benefits Investigation

Eligibility · Prior Authorization · Formulary · Patient OOP — one automated pass in 3 minutes.

Eligibility✓ Aetna PPO active
AWP per dose$22,400
Prior Authorization✓ Valid thru 12/31/26
Expected reimb.$18,670
Formulary✓ Specialty tier 4
Patient OOP$0.00 via PAP
BI complete ✓ 9:07 AM · 3 minutes · PA workflow auto-triggered

Prior Authorization

OnePulse Connect auto-submits Prior Authorization with clinical criteria, diagnosis documentation, and prescriber attestation.

1
Auto-submission — 9:08 AM
OnePulse Connect pulls ICD-10 G35, J-code J0202, clinical notes, EDSS score, prior therapy history (Tysabri — failed). Submits to Aetna via CoverMyMeds integration.
Pending
2
Real-time status check
OnePulse Connect pings the payer API. Criteria checklist auto-populated: step therapy ✓, diagnosis documentation ✓, prescriber NPI ✓, formulary exception if needed.
Tracking
3
Approval received — 9:31 AM · 23 min turnaround
Valid through 12/31/2026 · Quantity limit: 6 infusions/year · Auth # AET-2026-04419.
Approved

If PA Is Denied — The Appeal Path

OnePulse Connect keeps the case moving. Every denial triggers an automatic appeal workflow before the patient ever knows there was a problem.

!
Denial received — reason code flagged
OnePulse Connect parses denial reason: step therapy not met, medical necessity, or formulary exclusion. Routes to the correct appeal type automatically.
Denied
P1
Peer-to-peer review scheduled
OnePulse Connect alerts the prescriber and schedules a P2P call with the medical director. Packages clinical evidence: EDSS scores, prior treatment failures, published clinical guidelines.
In progress
A1
First-level appeal filed
Letter of medical necessity auto-generated. Supporting literature attached. Submitted within 24h of denial — within the payer appeal window. IRO escalation queued if needed.
Filed
Bridge supply initiated in parallel
Manufacturer free-drug bridge or samples requested automatically while the appeal resolves. Patient never experiences a gap in therapy.
No gap in care

Financial Assistance — Full Waterfall

OnePulse Connect searches every available assistance source simultaneously — manufacturer, foundation, state, and federal — before the patient is ever told what they owe.

1
Manufacturer Patient Assistance Program (PAP)
Genentech Access Solutions checked. Uninsured / underinsured patients: full free drug. Income threshold applied automatically. Enrollment packet auto-generated.
✓ Applied — $0
2
Manufacturer Co-pay Card / Co-pay Assistance
Ocrevus co-pay program checked. Commercially insured patients with remaining OOP: up to $25,000/year offset. eEnrollment completed in OnePulse Connect.
✓ Enrolled
3
Independent Foundation Grants
National MS Society, HealthWell Foundation, Patient Advocate Foundation, PAN Foundation — all checked for open grant cycles, eligibility, and application deadlines.
Checked — on file
4
State Pharmaceutical Assistance Programs (SPAP)
State-specific programs cross-referenced by patient zip code. EPIC, PACE, and equivalent programs flagged where applicable as payer-of-last-resort.
State verified
5
Medicare Extra Help / LIS + Medicaid dual eligibility
For Medicare patients: Low Income Subsidy screening automated. Dual-eligible patients routed to the correct pathway. Reimbursement protection maintained.
Screened — N/A

Care Path Selection: IOI or MID

Physician selects pathway — both models share the same OnePulse Connect platform, assessment engine, and outcomes infrastructure.

MID

Medically Integrated Dispensing

Physician dispenses oral or injectable therapy directly from the office. Patient receives medication from the provider's site of care, alleviating coordination with external pharmacies.

IOIselected for Ocrevus

In-Office Infusion

IV biologic administered in the physician's own infusion suite. Full nursing supervision, OnePulse Connect pre and post infusion assessment, real-time clinical monitoring.

Appointment
Today · 10:30 AMSuite 2 — Chair A
Concurrent Rx
Copaxone40 mg / mL
In-office stock · MID dispense
Nurse assigned
L. Fleming, RNDuration ~3.5 hrs
Pre-infusion Ax ✓
IOI Suite 2
+
MID Dispense
RPh counseling on demand
48h follow-up auto-set

Patient Communication

Automated HIPAA-compliant SMS at every milestone — PA status, $0 cost confirmed, appointment, follow-up, satisfaction survey.

OP
OnePulse Health
Shortcode 55400

Outcomes Tracking

Assessment scores, adherence, gap-in-therapy — OnePulse Connect builds the evidence base for every manufacturer conversation.

94%
Adherence rate
2.1
EDSS score — stable
0
Relapses this quarter
84
Patient Reported Outcomes Score / 100
Mfr. outcomes report auto-generated
CMS Star crosswalk complete
Next infusion auto-set · Gap-in-therapy tracked · Cycle complete — next queued · Mfr. data package ready

Dashboard

Unified view across every patient — track Rx, surface bottlenecks, prioritize follow-ups in real time.

47
Active patients
12
PAs in motion
$0
Avg patient OOP
96%
Adherence rate
Patient
Drug
Status
Activity
Maria G.
Ocrevus
In Treatment
10m ago
James R.
Skyrizi
PA Approved
1h ago
Patricia N.
Humira
PA Pending
2h ago
Linda T.
Tysabri
Appeal Filed
4h ago
Carlos M.
Stelara
Outcomes Logged
1d ago
Stage 1 of 8